HHR Journal Piece Puts 1961 UN Drug Treaty Back Under Fire

What the headline signals

HHR Journal put the 1961 Single Convention on Narcotic Drugs back at the center of the cannabis policy argument. The piece, indexed Nov. 11, carries the title “The Single Convention Has Been One of Our Biggest Nightmares.”

All the feed listing supplies is the headline and the publisher. It doesn't identify who is quoted, and CannIntel hasn't read the full piece, so this report doesn't attribute the line to anyone. Still, the word choice tells you how raw the treaty problem has become.

Why the treaty keeps coming up

The Single Convention, adopted in 1961, obliges parties to confine cannabis to medical and scientific use. Uruguay legalized adult-use in 2013 and Canada followed in 2018. The International Narcotics Control Board (INCB) has said such laws conflict with treaty obligations.

Change has come only at the margins. In December 2020, the UN Commission on Narcotic Drugs voted 27-25 with one abstention to drop cannabis from Schedule IV, following a WHO recommendation. Cannabis stayed in Schedule I.

Not a rewrite. A footnote.

The hemp and THCA angle

Article 28(2) exempts cannabis grown exclusively for industrial purposes, meaning fibre and seed, or for horticultural purposes. It says nothing about extracting cannabinoids or converting them, which is where today's hemp-derived THC market lives.

That gap matters because the U.S. definition of hemp turns on a chemistry question. The 2018 Farm Bill caps hemp at 0.3% delta-9 THC by dry weight. THCA, the raw acid form in flower, decarboxylates into delta-9 THC when heated, so regulators who count total THC use delta-9 plus 0.877 times THCA. Products that pass the first test can fail the second. Isomerization of CBD into other THC isomers adds another layer the treaty never contemplated.

Does the 1961 text reach those products? Nobody has settled that.

What operators should watch

Treaty pressure rarely hits hemp businesses directly, but it shapes the national rules that do. Countries that want to regulate cannabis, including Germany and Thailand, have had to design programs around treaty language instead of around public health data. That's an awkward way to write drug policy.

For full background on the treaty and its pressure points, see the CannIntel topic hub on the UN Single Convention and global cannabis policy.

This is unsettled. Expect enforcement to vary by country, and in the U.S. by state, until the delta-9-versus-total-THC question gets a firm answer.